SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-23-052148
Filing Date
2023-06-27
Accepted
2023-06-27 16:22:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ea180614-defa14a_hoththera.htm DEFA14A 9146
2 GRAPHIC image_001.jpg GRAPHIC 679008
3 GRAPHIC image_002.jpg GRAPHIC 434023
  Complete submission text file 0001213900-23-052148.txt   1543130
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38803 | Film No.: 231047579
SIC: 2834 Pharmaceutical Preparations